Use of ACE inhibitors and risk of community-acquired pneumonia: a review

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.64, Iss.6, 2008-06, pp. : 565-573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Use of Cefuroxime in Paediatric Community-Acquired Pneumonia

By Olivier C.

Pediatric Drugs, Vol. 2, Iss. 5, 2000-09 ,pp. : 331-343

Adis International

Access to resources Recommend Favorite

Tigecycline: In Community-Acquired Pneumonia

By McKeage Kate Keating Gillian M.

Drugs, Vol. 68, Iss. 18, 2008-01 ,pp. : 2633-2644

Adis International

Access to resources Recommend Favorite

Community‐Acquired Pneumonia

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 3, 2004-09 ,pp. : 212-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Azithromycin Extended Release: A Review of its Use in the Treatment of Acute Bacterial Sinusitis and Community-Acquired Pneumonia in the US

By Tracy Swainston Harrison Keam Susan J.

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 773-792

Adis International

Access to resources Recommend Favorite

Benefit-Risk Assessment of Telithromycin in the Treatment of Community-Acquired Pneumonia

By Brown Steven D.

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 561-575

Adis International

Access to resources Recommend Favorite